Target intelligence / Profile preview

No discrete pharmacological molecular target

Molecular classification
Other
01

Overview

The classification "No discrete pharmacological molecular target" is used to describe therapeutic agents that do not function by binding to a specific biological macromolecule, such as a protein receptor, enzyme, or transporter (DrugBank Online). Instead, these agents achieve their clinical utility through broad physical or chemical interactions within the physiological environment. For example, antacids like calcium carbonate work via a simple chemical neutralization of hydrochloric acid in the stomach, while osmotic laxatives like polyethylene glycol utilize osmotic pressure to increase stool water content (StatPearls: Antacids; PubMed: 25569441). Other substances in this category include activated charcoal, which acts as a physical adsorbent for toxins, and surfactants like simethicone that alter the surface tension of gas bubbles. Because these treatments lack a specific molecular "lock-and-key" interaction, their pharmacological profiles are governed by their bulk chemical properties and concentration. This designation is critical for pharmacological databases to categorize drugs that fall outside the traditional receptor-based paradigm of drug action.

Other names
Non-specific mechanism of actionPhysical/chemical mechanismNon-molecular mechanismNon-receptor mediated action
02

Mechanism of action

Drugs in this category exert therapeutic effects through non-specific physical or chemical processes, such as the direct neutralization of gastric acid, the creation of osmotic gradients to retain intestinal water, or the physical adsorption of toxins (DrugBank Online; StatPearls: Antacids).

03

Biological functions

Chemical neutralizationOsmotic pressure regulationAdsorptionPhysical barrier formationSurfactant activity
04

Disease associations

Gastroesophageal reflux diseaseConstipationPoisoningFlatulenceDry eye syndrome
05

Safety considerations

Electrolyte imbalanceMetabolic alkalosisReduced absorption of co-administered medicationsSystemic accumulation of non-absorbable ions in renal impairment
06

Interacting drugs

Magnesium hydroxide

7 more in the full profile.

07

Biomarkers

Gastric pHStool consistencySerum electrolyte levelsSerum osmolality

Beyond the preview

Go deeper on No discrete pharmacological molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No discrete pharmacological molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call